Anxiety Disorders

Populations and Risk Factors

Most common mental health category: ~19% of U.S. adults affected annually; lifetime prevalence ~31%
Women affected approximately 2:1 over men across all subtypes
Onset typically in adolescence or early adulthood; GAD mean onset age 30; panic disorder mean onset late 20s
Strong familial/genetic component — first-degree relatives have 4–6 times increased risk
History of physical, sexual, or emotional abuse significantly increases vulnerability, particularly for panic disorder and social anxiety
Comorbidities: major depression (60% co-occurrence), chronic stress, substance use disorders (self-medication), insomnia, irritable bowel syndrome, tension headache, temporomandibular joint dysfunction
Chronic medical conditions increase risk: cardiovascular disease, respiratory disease (COPD, asthma), chronic pain syndromes
Caffeine, stimulant use, and sleep deprivation lower the threshold for anxiety symptom activation

Causes and Pathophysiology

Limbic System Hyperactivation — The Core Mechanism

Amygdala-driven threat detection: The amygdala is the brain's primary threat detection center. In anxiety disorders, the amygdala has a lowered activation threshold — it identifies threat in situations that do not warrant a fight-or-flight response. This produces a chronic state of vigilance where the stress response is triggered by internal cues (thoughts, physical sensations) rather than actual external danger.
Hippocampal atrophy: Chronic cortisol exposure from sustained HPA axis activation damages hippocampal neurons. The hippocampus provides contextual memory — it tells the amygdala whether a stimulus is genuinely dangerous based on past experience. Hippocampal atrophy impairs this contextual modulation, leaving the amygdala's threat response unchecked.
Why this matters for palpation: The limbic hyperactivation drives a body-wide protective state that is neurologically mediated. The hypertonicity found in cervicothoracic muscles, jaw, and diaphragm is not from overuse or injury — it is the body's sustained preparation for a threat that the brain perceives as real. This means the muscle tone is cortically maintained and may resist purely mechanical treatment approaches unless the neurological state is also addressed.

Neurotransmitter Imbalances

GABA deficiency: Gamma-aminobutyric acid (GABA) is the brain's primary inhibitory neurotransmitter — it dampens neural excitability. Reduced GABA activity in anxiety disorders removes the "braking system" on excitatory circuits, producing neural hyperexcitability that manifests as muscle tension, hyperreflexia, and startle responses. This is why benzodiazepines (GABA agonists) provide immediate relief — they restore GABA-mediated inhibition.
Serotonin dysregulation: Serotonin modulates mood, sleep, appetite, and pain perception. Low serotonin in the prefrontal cortex reduces top-down inhibition of the amygdala. SSRIs work by increasing synaptic serotonin, gradually restoring prefrontal-amygdala regulation (which is why they take 4–6 weeks to reach full effect, unlike immediate-acting benzodiazepines).
Norepinephrine excess: Elevated norepinephrine from the locus coeruleus drives the physical symptoms of anxiety — tachycardia, tremor, diaphoresis, and muscle tension. This is why beta-blockers (which block norepinephrine at beta-adrenergic receptors) are used for performance anxiety.

HPA Axis and Cortisol

Chronic HPA axis activation produces sustained cortisol elevation, catabolizing muscle protein, weakening connective tissue, suppressing immune function, and contributing to the GI symptoms (cortisol diverts blood from the digestive tract)
Unlike PTSD (which shows reduced cortisol with increased receptor sensitivity), anxiety disorders typically show elevated cortisol — this is an important differential distinction

Breathing Pattern Dysfunction — The Anxiety-Specific Pattern

Hyperventilation: The most diagnostically significant breathing abnormality in anxiety. Rapid, shallow chest breathing reduces arterial CO2 (hypocapnia), which causes respiratory alkalosis, cerebral vasoconstriction, and increased neural excitability. The patient experiences this as lightheadedness, tingling in extremities, chest tightness, and a sensation of inability to get a full breath — which further increases anxiety (panic cycle).
Breath-holding: Some anxiety presentations involve intermittent breath-holding (apneustic pattern) — the patient unconsciously holds their breath during periods of heightened vigilance, then gasps. This produces irregular oxygen/CO2 fluctuations that destabilize autonomic tone.
Chest breathing with accessory muscle recruitment: Similar to chronic stress but typically more pronounced, with visible clavicular elevation, SCM and scalene hyperactivity, and pectoralis minor shortening. The diaphragm is functionally inhibited.
Why this matters for MT: The breathing dysfunction in anxiety is more severe than in chronic stress and is bidirectional with the autonomic state. Hyperventilation both results from and perpetuates the sympathetic activation. Addressing the breathing pattern is not optional — it is a primary treatment target.

Autonomic Hyperactivation

Sympathetic overdrive manifestations: Tachycardia, palpitations, tremor, diaphoresis, GI disturbance (nausea, diarrhea, abdominal cramping), urinary urgency, dry mouth, pupil dilation — these are the features that distinguish anxiety from pure chronic stress
Abdominal guarding: GI-related anxiety symptoms (IBS overlap, stress-driven visceral hypersensitivity) produce protective abdominal wall guarding — the rectus abdominis, obliques, and transversus abdominis become hypertonic, restricting diaphragmatic descent and contributing to the breathing dysfunction

Signs and Symptoms

Musculoskeletal Manifestations

Cervicothoracic hypertonicity — upper trapezius, levator scapulae, SCM, scalenes, rhomboids in a bilateral, symmetrical pattern
Jaw clenching/bruxism — masseter and temporalis hypertonicity, often with TMJ symptoms (clicking, limited opening, temporal headache)
Postural guarding — elevated shoulders, protracted scapulae, forward head posture; trunk rigidity from erector spinae and abdominal co-contraction
Tension headache — bilateral band-like pressure from pericranial muscle hypertonicity
Abdominal wall guarding — rectus abdominis and oblique hypertonicity from GI-related visceral referral

Autonomic Manifestations (Distinguishing from Chronic Stress)

Palpitations or tachycardia — resting HR frequently >85 bpm
Trembling or visible tremor in hands
Diaphoresis — clammy palms, visible perspiration
GI disturbance: nausea, cramping, urgency, IBS-pattern symptoms
Sensation of dyspnea ("can't get a full breath") despite normal oxygen saturation
Paresthesias in extremities from hyperventilation-induced respiratory alkalosis

Subtype-Specific Features

Subtype	Distinguishing MSK Feature	Autonomic Feature
GAD	Chronic diffuse muscle tension; "always tense"; insomnia from inability to relax	Persistent low-grade autonomic arousal; fatigue from sustained activation
Panic disorder	Acute episodes of intense muscle tension with chest tightness mimicking cardiac event	Paroxysmal tachycardia, hyperventilation, tremor, diaphoresis; "fear of fear" (anticipatory anxiety)
Social anxiety	Facial/cervical tension; blushing; SCM/platysma guarding	Visible tremor, diaphoresis, GI urgency in social situations
Specific phobias	Minimal baseline MSK involvement; acute guarding only when triggered	Acute autonomic surge when exposed to the phobic stimulus

Assessment Profile

Subjective Presentation

Chief complaint: "I'm tense all the time and I can't stop it." "My shoulders are up by my ears." "I get this tightness in my chest and I can't breathe." May present primarily with physical symptoms (headache, jaw pain, neck tension) without identifying anxiety as the driver.
Pain quality: Bilateral cervicothoracic aching and stiffness; jaw tension and headache; chest tightness (from accessory muscle overuse and costal restriction, not cardiac); abdominal cramping or "knot in my stomach"; tingling in hands/feet during episodes (hyperventilation-induced)
Onset: Often longstanding — many patients have had anxiety symptoms since adolescence; may identify a worsening period linked to life events; physical symptoms may precede formal anxiety diagnosis by years
Aggravating factors: Stressful situations, social demands (social anxiety), crowded/enclosed spaces (panic disorder), sleep deprivation, caffeine, stimulants, being in unfamiliar environments, being touched without warning, lying supine (vulnerability position for some patients)
Easing factors: Familiar environments, predictable routines, controlled breathing, exercise, massage therapy (when the therapeutic relationship is established and trust is present), anxiolytic medication
Red flags: Chest pain with exertional component, radiation to left arm/jaw, or associated dyspnea → cardiac screen before attributing to anxiety; do not treat until cardiac etiology excluded. Suicidal ideation → immediate mental health referral. Acute panic with depersonalization/derealization lasting >30 minutes → emergency evaluation.

Observation

Local inspection: Visible sympathetic activation — flushing, diaphoresis (particularly palms, forehead), visible tremor in hands; restlessness, inability to be still; facial tension (furrowed brow, clenched jaw); rapid or irregular breathing pattern visible; sighing
Posture: Elevated shoulders (bilateral), protracted scapulae, forward head posture, increased thoracic kyphosis; trunk rigidity from co-contraction of erector spinae and abdominal wall; "bracing" posture — appearing ready to move or flee; shoulders may visibly elevate further during conversation about stressful topics
Gait: Usually normal structurally; may show hurried, tense pattern; restless, pacing quality in some patients

Palpation

Tone: Bilateral cervicothoracic hypertonicity — upper trapezius, levator scapulae, SCM, scalenes, suboccipitals, rhomboids, erector spinae; jaw muscles (masseter, temporalis) often significantly hypertonic; abdominal wall guarding (rectus abdominis, obliques) from GI-related visceral referral and protective bracing; diaphragm palpation at costal margin reveals restricted excursion. Tone may fluctuate during the session — increases with anxiety triggers (unexpected sounds, position changes) and decreases as trust builds.
Tenderness: Bilateral cervicothoracic tenderness following the same distribution as hypertonicity; trigger points in upper trapezius (temporal referral), SCM (frontal/periorbital referral), masseter (temporal/ear referral); suboccipital tenderness; abdominal wall tenderness on palpation (distinguish from visceral pathology — muscular tenderness is superficial, reproducible, and changes with position). Tenderness may be heightened by autonomic state — the same pressure may be painful on a high-anxiety day and comfortable on a calm day.
Temperature: Warm, moist palms (sympathetic activation); may show mild warmth over hypertonic cervicothoracic muscles; overall body temperature normal; cold extremities possible from peripheral vasoconstriction during acute anxiety
Tissue quality: Similar to chronic stress — ropy, fibrotic bands in chronically hypertonic muscles (upper trapezius, levator scapulae); fascial restriction in the cervicothoracic region; pectoralis minor and anterior cervical fascia shortened from chronic chest-dominant breathing; abdominal wall may feel rigid and board-like during acute anxiety episodes but soften with relaxation

Motion Assessment

AROM: Cervical ROM restricted, particularly lateral flexion and rotation; thoracolumbar rotation may be limited from erector spinae/abdominal co-contraction; movements are guarded and tentative; jaw opening may be limited (<40 mm); the patient may guard more during assessment than during treatment (assessment itself is anxiety-provoking for some patients)
PROM / end-feel: Firm muscular end-feel — neuromuscular guarding, not capsular; PROM exceeds AROM; end-feel may change during the session as the patient relaxes (initially firm guarding → softer muscular end-feel); if capsular end-feel found, investigate comorbid structural pathology
Resisted testing: Normal strength; pain may be reported with sustained contraction (fatigue from chronic hypertonicity); no myotomal pattern of weakness

Special Test Cluster

Anxiety disorders produce musculoskeletal findings through autonomic and neuromuscular pathways rather than structural pathology. The cluster below quantifies autonomic state, screens breathing dysfunction, and rules out conditions whose symptoms overlap with anxiety-driven presentations.

Test	Positive Finding	Purpose
Vital signs (resting HR, BP, respiratory rate) (CMTO)	HR >85 bpm; BP elevated; RR >16/min	Quantify autonomic activation; distinguish anxiety-driven tachycardia from cardiac pathology; establish baseline
Breathing pattern assessment (CMTO)	Chest-dominant breathing; clavicular elevation; apneustic pauses or hyperventilation; RR >16/min; reduced diaphragmatic excursion	Identify hyperventilation or breath-holding pattern driving autonomic cycle
Postural assessment (CMTO)	Elevated shoulders, forward head, protracted scapulae, trunk rigidity	Document guarding posture; track changes over treatment course
TMJ screen (supplementary)	Limited opening, deviation, masseter/temporalis tenderness, clicking	Screen for bruxism/TMJ involvement; common anxiety comorbidity
Neurological screen (dermatome/myotome/reflex) (CMTO — rule out)	Normal — no focal deficits	Rule out cervical radiculopathy, peripheral neuropathy, or CNS pathology; paresthesias from hyperventilation are bilateral and non-dermatomal

Note: Bilateral hand/foot tingling reported during anxiety episodes is typically hyperventilation-induced respiratory alkalosis (bilateral, symmetrical, associated with breathing changes) — not peripheral neuropathy (glove-and-stocking, persistent, associated with sensory loss on testing).

Differential Assessment

Condition	Key Distinguishing Feature
Chronic stress	Significant overlap; chronic stress lacks the prominent autonomic features (palpitations, tremor, diaphoresis, GI urgency) and the cognitive component (catastrophizing, persistent worry, anticipatory anxiety) that characterize anxiety disorders
Hyperthyroidism	Tremor, tachycardia, weight loss, heat intolerance, exophthalmos; elevated T3/T4 with suppressed TSH; anxiety symptoms resolve with thyroid treatment
Cardiac arrhythmia	Palpitations with irregular pulse; symptoms during exertion (anxiety palpitations typically at rest or with stress); ECG required for differentiation — do not diagnose palpitations as anxiety without cardiac clearance
Pheochromocytoma	Episodic hypertension, headache, diaphoresis, tachycardia; rare but dangerous; symptoms paroxysmal and severe; elevated catecholamines on laboratory testing
Fibromyalgia	Widespread pain at ≥7 WPI sites; tender points hypotonic; fatigue and cognitive dysfunction more prominent than autonomic features; central sensitization rather than autonomic hyperactivation

CMTO Exam Relevance

Classified as a mental health condition (A4) with primary musculoskeletal and autonomic manifestation
Medication knowledge is critical: Benzodiazepines (lorazepam, clonazepam) cause sedation and orthostatic hypotension — assist off table; SSRIs (sertraline, escitalopram) take 4–6 weeks for full effect and cause orthostatic hypotension; beta-blockers (propranolol) mask tachycardia — cannot use HR as a treatment response indicator
Differentiating anxiety-driven hyperventilation paresthesias (bilateral, symmetrical, associated with breathing changes) from peripheral neuropathy (dermatomal, persistent, with sensory loss) is a commonly tested concept
Know that PROM > AROM with muscular end-feel indicates neuromuscular guarding, not structural restriction
Understand the concept of "tactile defensiveness" — some anxiety patients involuntarily perceive touch as threatening; this is a neurological phenomenon, not a behavioral choice
The distinction between chronic stress and anxiety disorders centers on the autonomic and cognitive features exceeding the musculoskeletal presentation

Massage Therapy Considerations

Primary therapeutic target: The autonomic hyperactivation state. MT activates the parasympathetic nervous system through sustained non-noxious sensory input, reducing sympathetic tone, lowering circulating catecholamines and cortisol, and providing a safe somatic experience that counteracts the threat-detection loop. The muscle releases are downstream effects of the neurological shift.
Sequencing logic: Safety and trust first, then tissue work. The therapeutic relationship and environmental control are preconditions for effective treatment. If the patient does not feel safe, their autonomic nervous system will override any manual technique — deeper work will increase guarding rather than release it.
Safety / contraindications: The primary safety concern is psychological, not physical — touch may be perceived as threatening, particularly for patients with abuse history. Sessions must be adaptable: offer choices (prone vs. side-lying, draped vs. through clothing, door open vs. closed), maintain continuous verbal check-ins, and be prepared for emotional catharsis. For patients on benzodiazepines, orthostatic hypotension risk requires assisted transitions off the table. For patients on SSRIs, altered pain perception requires conservative pressure. Avoid sudden movements, unexpected touch, or unpredictable changes in pressure or rhythm — these trigger the startle response.
Heat/cold guidance: Warmth generally well received (heat packs, warm room, heated table) — promotes parasympathetic shift. Cold is avoided — increases sympathetic tone and may trigger anxiety in sensitive patients. Environmental temperature should be slightly warm and consistent.

Treatment Plan Foundation

Clinical Goals

Reduce autonomic hyperactivation through parasympathetic nervous system engagement (measurable: reduction in HR, RR, visible relaxation)
Release cervicothoracic and jaw hypertonicity patterns driven by chronic sympathetic dominance
Restore diaphragmatic breathing and reduce hyperventilation pattern
Provide a safe, predictable somatic experience that builds body trust

Position

Starting position is patient-directed — offer choice between prone, supine, and side-lying; prone (face-down) is often least threatening as the patient does not need to make eye contact; however, some anxiety patients find face cradle claustrophobic — side-lying is an excellent alternative
Bolstering for maximum comfort — any positional discomfort will activate the vigilance system
Minimize position changes — each change is a transition that may re-trigger guarding; if a change is needed, announce it in advance

Session Sequence

Grounding contact — place hands on upper back (prone) or shoulders (supine/side-lying) with no movement for 30–60 seconds; match breathing rhythm; this establishes safety and allows the patient's nervous system to habituate to contact
Slow, rhythmic effleurage to the posterior trunk — broad, predictable strokes; the rhythm should be slow and consistent (one stroke per patient breath cycle); this activates the parasympathetic response through sustained non-noxious sensory input
Paravertebral stroking — slow, sustained strokes along the erector spinae from T12 to C7; dampens sympathetic chain output; moderate pressure within tolerance
Upper trapezius and levator scapulae release — myofascial release, longitudinal stripping, sustained compression; approach gradually — increasing pressure only after the patient's guarding decreases; trigger point work if taut bands identified
Cervical and suboccipital release — gentle sustained compression of the suboccipital group; address SCM and scalene hypertonicity; this region directly influences autonomic regulation through the vagus nerve and cervical sympathetic ganglia
Diaphragmatic breathing re-training — guide the patient through slow diaphragmatic breathing (4-count inhale, 6-count exhale) with hands at the costal margin; this directly addresses the hyperventilation/chest-breathing pattern; may be performed at any point during the session when the patient is receptive
Abdominal release — [only with explicit consent and when guarding has decreased] — gentle effleurage and myofascial release to the abdominal wall; addresses GI-related guarding; deeply vulnerable for anxious patients — proceed only with clear verbal consent and continuous feedback
Closing sequence — return to slow, broad, light strokes; progressive pressure reduction; allow extended rest period before moving; do not rush the transition to sitting/standing

Adjunct Modalities

Hydrotherapy: Pre-treatment moist heat to the cervicothoracic region — promotes tissue pliability and parasympathetic shift. Warm foot bath at intake reduces overall arousal. Avoid cold applications — cold increases sympathetic activation and may trigger anxiety. Room temperature should be warm and stable (cold drafts are anxiety-provoking).
Remedial exercise (on-table): Diaphragmatic breathing re-training (primary intervention). PIR for upper trapezius and levator scapulae after manual release. Progressive muscle relaxation sequence (contract-relax through major muscle groups) — particularly effective for patients who have difficulty "letting go" of tension voluntarily.

Exam Station Notes

Demonstrate patient-centered approach — offer positioning choices, explain what you are doing before doing it, check in verbally before changing regions or increasing pressure
Verbalize recognition of neuromuscular vs. structural findings — "The end-feel is muscular guarding, not capsular restriction — this is consistent with anxiety-related hypertonicity"
Demonstrate breathing assessment — identify chest-dominant pattern and intervene with diaphragmatic instruction
Show awareness of medication effects — verbalize orthostatic hypotension precautions for benzodiazepine users

Verbal Notes

Session orientation: "Before we begin, I want you to know that you're in control of this session. If anything feels uncomfortable — the pressure, the position, anything at all — just tell me and I'll adjust. There's no wrong thing to say."
Breathing guidance: "I notice your breathing is mostly in your upper chest. I'm going to guide you through a slower breathing pattern — this helps your nervous system shift out of the stress response. Breathe in slowly through your nose, letting your belly expand, then out slowly through your mouth."
Post-treatment transition: "Take your time sitting up. There's no rush. Some people feel a little lightheaded after deep relaxation, especially if you take medication for anxiety — just sit for a moment before standing."

Self-Care

Diaphragmatic breathing — 4-count inhale through nose (abdominal expansion), 6-count exhale through mouth; 5 minutes, 2–3 times daily; can be used as an acute intervention during anxiety episodes to interrupt hyperventilation
Progressive muscle relaxation — systematic contract-relax through major muscle groups (hands, forearms, shoulders, jaw, forehead); 10 minutes before bed; teaches voluntary muscle release and improves body awareness
Regular moderate aerobic exercise — walking, swimming, cycling; 20–30 minutes, 3–5 times per week; exercise is the most effective non-pharmacological anxiolytic through endorphin release and HPA axis regulation
Caffeine reduction — anxiety-sensitive individuals should limit caffeine to <200 mg/day (approximately 1 cup of coffee); caffeine directly antagonizes adenosine receptors and increases norepinephrine release, lowering the anxiety threshold

Key Takeaways

Anxiety disorders produce musculoskeletal hypertonicity through limbic system hyperactivation and sustained sympathetic nervous system dominance — the muscle tension is cortically driven, not from tissue pathology
The key clinical distinction from chronic stress is the prominence of autonomic features: tachycardia, hyperventilation, tremor, diaphoresis, GI disturbance, and the cognitive component (catastrophizing, persistent worry)
Breathing dysfunction in anxiety is more severe than in chronic stress — hyperventilation produces respiratory alkalosis causing paresthesias, lightheadedness, and chest tightness that mimic cardiac symptoms
The primary safety concern is psychological — touch may be perceived as threatening; session control must be explicitly given to the patient, and the therapeutic environment must be predictable and safe
Benzodiazepines create significant orthostatic hypotension risk; SSRIs alter pain perception; beta-blockers mask tachycardia — medication awareness is essential for safe practice
Bilateral hand/foot tingling in anxiety is hyperventilation-induced (respiratory alkalosis), not peripheral neuropathy — the mechanism is reduced arterial CO2, not nerve compression